The prognostic value of sST2 in connective tissue disease patients with pulmonary hypertension

ST2 is a biomarker of pediatric pulmonary arterial hypertension severity and clinical worsening.

(2021) Megan Griffiths et al.   CHEST

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

(2019) Martin Aringer et al.   ANNALS OF THE RHEUMATIC DISEASES

ST2/IL-33 signaling in cardiac fibrosis

(2019) Elena Vianello et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Soluble ST2 in Heart Failure

(2018) Cian P. McCarthy et al.   Heart Failure Clinics

IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells

(2018) Jie Liu et al.   EBioMedicine

2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome

(2016) Caroline H Shiboski et al.   ANNALS OF THE RHEUMATIC DISEASES

Soluble ST2—Analytical Considerations

(2015) Thomas Mueller et al.   AMERICAN JOURNAL OF CARDIOLOGY

The Biology of ST2: The International ST2 Consensus Panel

(2015) Domingo A. Pascual-Figal et al.   AMERICAN JOURNAL OF CARDIOLOGY

Comparison of Treatment Response in Idiopathic and Connective Tissue Disease–associated Pulmonary Arterial Hypertension

(2015) Rennie L. Rhee et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

(2015) Nazzareno Galiè et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension

(2014) Dongmin Shao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Plasma Soluble ST2 Levels Correlate With Disease Severity and Predict Clinical Worsening in Patients With Pulmonary Arterial Hypertension

(2014) Ya-Guo Zheng et al.   CLINICAL CARDIOLOGY

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

(2013) Frank van den Hoogen et al.   ANNALS OF THE RHEUMATIC DISEASES

Serum levels of the soluble IL-1 receptor family member ST2 and right ventricular dysfunction

(2013) Lucia Agoston-Coldea et al.   Biomarkers in Medicine

Soluble ST2 and N-terminal pro-Brain Natriuretic Peptide Combination

(2013) Ayako Chida et al.   CIRCULATION JOURNAL

Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension

(2013) Guido Carlomagno et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

(2012) Raymond L. Benza et al.   CHEST

The Presage®ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2

(2012) Thomas Mueller et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Association of ST2 levels with cardiac structure and function and mortality in outpatients

(2010) Lori B. Daniels et al.   AMERICAN HEART JOURNAL

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) D. Aletaha et al.   ANNALS OF THE RHEUMATIC DISEASES

Primary sources and immunological prerequisites for sST2 secretion in humans

(2010) M. Mildner et al.   CARDIOVASCULAR RESEARCH

Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL

(2010) Lorinda Chung et al.   CHEST

Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography

(2010) Lawrence G. Rudski et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

The Right Ventricle Under Pressure

(2009) Harm J. Bogaard et al.   CHEST